OpenFilings

CHINA PHARMA HOLDINGS, INC.

Form10-K

Report Period2023-12-31

Date Filed2024-04-01

Time Filed16:06:16

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

ANNUAL REPORT
THE FIRST AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THE COMPANY
THE SECOND AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THE COMPANY
LOAN SETTLEMENT AGREEMENT BETWEEN CHINA PHARMA HOLDINGS, INC. AND MS. ZHILIN LI
TECHNOLOGY TRANSFER AGREEMENT BETWEEN HAINAN HELPSON MEDICAL & BIOTECHNOLOGY CO.
TECHNOLOGY TRANSFER AGREEMENT BETWEEN HAINAN HELPSON MEDICAL & BIOTECHNOLOGY CO.
OFFICE LEASE FOR SECOND FLOOR OF THE COMPANY'S PRINCIPAL EXECUTIVE OFFICE DATED
OFFICE LEASE FOR THIRD FLOOR OF THE COMPANY'S PRINCIPAL EXECUTIVE OFFICE DATED J
CONSENT OF THE INDEPENDENT ACCOUNTING FIRM.
CERTIFICATION
CERTIFICATION
CERTIFICATION
COMPENSATION RECOVERY POLICY OF THE COMPANY
Filing on SEC Edgar